Fighting Opioid Addiction: AIIMS launches mobile methadone vans to take treatment to inner city neighbourhoods

Published On 2019-03-23 08:34 GMT   |   Update On 2019-03-23 08:34 GMT
Advertisement
AIIMS mobile methadone dispensing unit plans to bridge this gap and improve retention of patients into treatment enabling them to work and lead a healthier life, Dr Rao said.

New Delhi: In a first-of-its-kind initiative, the All India Institute of Medical Sciences Friday launched mobile methadone vans to provide treatment to opioid addicts in inner-city neighbourhoods.


As a pilot project, the National Drug Dependence Treatment Centre (NDDTC) of AIIMS has initiated the new service of delivering methadone through a mobile van in East Delhi.

Advertisement

Opioid addiction is a significant problem in India, the professor at NDDTC Dr Atul Ambekar said, adding these people require medicines such as methadone or buprenorphine for getting rid of the addiction.


Methadone is a prescription drug given in a syrup form to patients as it helps in controlling the craving and withdrawals due to opioid addiction.


The drug usually comes in liquid form but is also available in powder and tablet variants. It is usually taken under the supervision of a doctor because of its potential for abuse, Ambekar said.


Read Also: AIIMS Patna releases vacancies for Junior, Senior Resident posts; Check out Details


There are very few treatment centres providing these medicines while the need is very high. It is estimated that less than 2 per cent of the population addicted to opioids in India is receiving this treatment, which is recommended by various UN bodies and the World Health Organization (WHO)," Ambekar said.


A recently released government survey report "Prevalence and Extent of Substance Use in India", estimated that India has about 28 lakh people affected by addiction to opioids such as heroin, opium and various pharmaceutical products.


Since methadone is a highly regulated medicine, it is only provided as daily observed treatment. It is available in just about a dozen cities in India, in charge of the methadone clinic at NDDTC Dr Ravindra Rao said.


"Patients often find it difficult to come to the clinic daily to receive methadone, which leads to them dropping out of treatment midway," Rao informed.


Read Also: AIIMS to get special unit to aid rape survivors


The mobile methadone dispensing unit plans to bridge this gap and improve retention of patients into treatment enabling them to work and lead a healthier life, Dr Rao said.


Currently, such dispensing vans or buses are available in few select developed countries in the world, such as USA, Portugal, Spain, Canada and the Netherlands.


With the launch of mobile delivery of methadone, India joins this elite club, he said. In fact, India is the first country in the South Asian region to initiate these services, Rao claimed.


The van will be parked at strategic places in East Delhi and adjoining areas for a fixed time period in the day where the patients can come and receive their medicine without having to travel to the main clinic.


"In the trial run for the last two weeks, we already have more than two dozen patients enrolled in the facility and the response is very encouraging," he said.


Based on the success of this initiative, this new approach can be scaled-up in different parts of the city and country.


At the national level, the most commonly used opioid is heroin (used by 1.14 per cent of the people surveyed), followed by pharmaceutical opioids (used by 0.96 per cent of the people surveyed) and opium (used by 0.52 per cent of the surveyed), the survey found.


Read Also: Long Waiting List: New OT complex for Orthopaedic surgeries set up at AIIMS


Approximately 60 lakh people are estimated to have opioid use disorders (harmful or dependent pattern) in the country, more than half are contributed by just a few states -- Uttar Pradesh, Punjab, Haryana, Delhi, Maharashtra, Rajasthan, Andhra Pradesh and Gujarat.


 

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News